CZ48, chemically camptothecin-20- O-propionate hydrate, is currently under clinical investigation. The kinetics of the metabolite camptothecin (CPT) formation and of CZ48 depletion in mouse and human liver microsomes in the presence or absence of NADPH was examined. The formation rate of camptothecin in human liver microsomes was significantly higher than that in mouse with mean K ms of 1.9 and 0.5 nM and V maxs of 9.3 and 2.2 pmol/min/mg, respectively. However, the apparent intrinsic clearance ( V max/ K m) ratios for camptothecin in human and mouse liver microsomes were not significantly different from each other (4.9 versus 4.4) in the presence of NADPH. The depletion of CZ48 in human microsomes was four times faster with 4.55% of CZ48 remaining intact while in mouse 19.11% of the drug remained unchanged after 60 min. These results suggest that there is a remarkable species difference of CZ48 biotransformation between human and mouse. The depletion rate of CZ48 in human liver microsomes is considerably higher than that in the mouse.
References
[1]
Guengerrich, F.P. Cytochrome P450 and chemical toxicity. Chem. Res. Toxicol 2008, 21, 70–83.
[2]
Emoto, C.; Murayama, N.; Rostami-Hodjegan, A.; Yamazaki, H. Methodologies for investigating drug metabolism at the early drug discovery stage: Prediction of hepatic drug clearance and P450 contribution. Curr. Drug Metab 2010, 11, 678–685.
[3]
Singh, S.S. Preclinical pharmacokinetics: An approach towards safer and efficacious drugs. Curr. Drug Metab 2006, 7, 165–182.
[4]
Cao, Z.; Kozielski, A.; Liu, X.; Wang, Y.; Vardeman, D.; Giovanella, B. Crystalline camptothecin-20(S)-O-propionate hydrate: A novel anticancer agent with strong activity against 19 human tumor xenografts. Cancer Res 2009, 69, 4742–4749.
[5]
Ludden, L.K.; Ludden, T.M.; Collins, J.M.; Pentikis, H.S.; Strong, J.M. Effect of albumin on the estimation, in vitro, of phenytoin Vmax and Km values: Implications for clinical correlation. J. Pharmacol. Exp. Ther 1997, 282, 391–396.
[6]
Vickers, A.E.; Fischer, V.; Connors, S.; Fisher, R.L.; Baldeck, J.P.; Maurer, G.; Brendel, K. Cyclosporin A metabolism in human liver, kidney, and intestine slices: Comparision to rat and dog slices and human cell lines. Drug Metab. Dispos 1992, 20, 802–809.
[7]
Vickers, A.E.; Connors, S.; Zollinger, M.; Biggi, W.A.; Larrauri, A.; Vogellaar, J.P.; Brendel, K. The biotransformation of the ergot derivative CQA 206-291 in human, dog and rat liver slice cultures and prediction of in vivo plasma clearance. Drug Metab. Dispos 1993, 21, 454–459.
[8]
Lin, J.; Lu, A.Y.H. Inhibition and induction of P450 and the clinical implications. Clin. Pharmacokinet 1998, 35, 361–390.
[9]
Cao, Z.; Harris, N.; Kozielski, A.; Vardeman, D.; Stehlin, J.; Giovanella, B. Alkyl esters of camptothecin and 9-nitrocamptothecin: Synthesis, in vitro pharmacokinetics, toxicity, and antitumor activity. J. Med. Chem 1998, 41, 31–37.
[10]
Burke, T.G. Chemistry of the camptothecins in the bloodstream: Drug stabilization and optimization of activity in the camptothecins—From discovery to patients. Ann. N. Y. Acad. Sci 1993, 803, 29–31.
[11]
Wani, M.C.; Ronman, P.E.; Lindley, L.T.; Wall, M.E. Plant antitumor agents. 18. Synthesis and biological activity of camptothecin analogs. J. Med. Chem 1980, 23, 554–560.
[12]
Cao, Z. Sulfuric acid-catalyzed preparation of camptothecin esters. Open J. Med. Chem 2012. in press.
[13]
Fujino, H.; Yamada, I.; Shimada, S.; Yoneda, M.; Kojima, J. Metabolic fate of Pitavastatin, a new inhibitor of HMG-CoA reductase: Human UDP-glucuronosyltransferase enzymes involved in lactonization. Xenobiotica 2003, 33, 27–41.
[14]
Fujino, H.; Saito, T.; Tsunenari, Y.; Kojima, J.; Sakaeda, T. Metabolic properties of the acid and lactone form of HMG-CoA reductase inhibitors. Xenobiotica 2004, 34, 961–971.
[15]
Liu, X.; Wang, Y.; Vardeman, D.; Cao, Z.; Giovanella, B. Development and validation of a reversed-phase HPLC with fluorescence detector method for simultaneous determination of CZ48 and its active metabolite camptothecin in mouse plasma. J. Chromatogr. B Anal. Technol. Biomed. Life Sci 2008, 867, 84–89.
